| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.001 |